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Summary 
Background  
Diarrhoeal diseases are among the leading causes of illness and death among children in 
developing countries, and do also cause considerable morbidity in industrialized countries. 
Enteropathogenic E. coli (EPEC), characterized by its ability to induce “attaching and 
effacing” (A/E) lesions the intestinal epithelium, is recognized as an important diarrheagenic 
agent in developing countries. Recently, EPEC has also been reported to be prevalent in the 
industrialized part of the world. Two main classes of EPEC have been recognized: typical 
EPEC has the ability to adhere to epithelial cells in discrete microcolonies, named “localized 
adherence” (LA). This trait is encoded by genes on a plasmid, called the EPEC adherence 
factor (EAF). Atypical EPEC does not contain the EAF and is not able to produce LA. 
 
Aims 
The aim of the study was to investigate the prevalence of EPEC and its epidemiological 
association with childhood diarrhoea in Norway. We also wanted to characterize the EPEC 
strains identified in the study by phenotypic and genotypic methods, and to search for 
bacterial factors statistically linked with diarrhoeal disease. 
 
Materials and methods 
The study was conducted in the County of Sør-Trøndelag, Norway. The prevalence of EPEC 
was first investigated in a retrospective laboratory based study of the aetiology of diarrhoea in 
children less than two years of age. Next a case-control study was carried out in children less 
than five years old. Cases were recruited as in the previous study, and healthy controls were 
recruited through Maternal and Child Health Centres. EPEC was identified by PCR, and the 
bacterial strains were characterized by DNA microarray, multilocus sequence typing, pulsed-
field gel electrophoresis (PFGE) and serotyping. 
 
Results 
EPEC was the most frequently identified enteropathogenic agent in the retrospective study, 
and was isolated from 38 (15.1%) of 251 children less than five years of age with diarrhoea in 
the case-control study. Strains of the EPEC pathotype were also common in healthy children 
where they were isolated from 21 (10%) of 210 subjects. There was no overall statistical 
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association between EPEC and diarrhoea (P=0.3). EPEC strains were rarely diagnosed in 
children with severe diarrhoea, and were less common in children less than 12 months of age.  
The majority of strains, 56/58 strains in the case-control study, were classified as 
atypical EPEC. The atypical EPEC strains showed extensive heterogeneity in sequence types 
and PFGE profiles. The strains were separated in three clusters based on all the virulence 
genes identified: one large cluster included all phylogenetic group A, B1 and D strains, and 
two smaller clusters consisted exclusively of phylogenetic group B2 strains. There was also 
considerable variation in serotypes, and almost half the strains were O serogroup non-typable.  
 Among a total of 95 putative virulence genes detected, seven genes were positively 
statistically associated with diarrhoea. Among these, the strongest statistical association was 
observed for the pathogenicity island OI-122 gene efa1/lifA (P=0.0002). The phylogenetic 
marker gene yjaA was strongly negatively associated with diarrhoea (P=0.0004).  
The atypical EPEC strains could be classified in two virulence groups based on their 
content of virulence genes positively and negatively associated with diarrhoea. Strains 
belonging to the group which was not associated with diarrhoeal disease should probably be 
considered as colonizers which do not cause disease. The frequent isolation of such strains 
may be due to their apparent propensity for protracted colonization. Strains belonging to the 
other virulence group, which was significantly associated with diarrhoea, were isolated both 
from patients with acute and protracted disease. 
 
Conclusions 
EPEC was frequently isolated from Norwegian children both with and without diarrhoea, but 
was rarely associated with severe diarrhoea. The majority of EPEC strains were characterized 
as atypical EPEC. Genetic characterization showed extensive heterogeneity among the 
atypical EPEC strains in the study. Several virulence genes were positively and negatively 
statistically associated with diarrhoea, and the strains could be classified in two virulence 
groups based on their content of these genes: one group was not associated with diarrhoea, but 
appeared to be associated with protracted colonization. The other group was associated with 
both acute and protracted diarrhoea. 
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1  Introduction 
1.1  Diarrhoea – a global perspective 
Infections of the gastrointestinal tract are among the world’s leading causes of illness and 
death among children. Recently such infections were reported to cause more than 3.2 disease 
episodes per year in children under the age of five in developing countries (125). They have 
also been estimated to be the third most common cause of death by infectious diseases, only 
preceded by lower respiratory tract infections and HIV/AIDS (138). Globally 21% of all 
deaths in children under five years of age are estimated to be due to diarrhoeal infections 
(125). In recent years studies from several developing countries have shown that diarrhoeal 
diseases also cause considerable lasting disabilities both in physical growth and fitness, and in 
cognitive skills and school performance (85). Disabilities linked to diarrhoeal diseases in 
middle and low income countries have been estimated to account for 58.7 million years of lost 
healthy life (termed Disability Adjusted Life Years, DALYs) (138). 
The incidence of diarrhoeal diseases does not appear to have changed much in recent 
years in spite of considerable efforts invested in control measures in this period (117). 
However, there has been a steady decline in diarrhoeal mortality during the last thirty years. 
Based on data from longitudinal studies using active surveillance, a reduction in diarrhoeal 
mortality was reported from 4.6 million deaths per year before 1980 (214), to 3.3 million in 
the period 1980 to 1990 (14), and to about 2.6 million deaths per year toward the end of the 
1990s (125). Although there is some uncertainty in the figures, as evidenced by alternative 
estimates as low as 2.1 and 1.6 million deaths per year for the period 1990 to 2000 (117,174), 
these data show that a definite trend of reduced diarrhoeal mortality took place towards the 
end of the 20th century. This reduction is mainly attributed to oral rehydration therapy which 
was introduced during this period, and is now the mainstay of diarrhoea treatment in most 
developing countries (235).  
In high-income countries children rarely die due to diarrhoeal diseases. Still, 
diarrhoeal episodes are common also in this part of the world. Recently an incidence of 740-
900 episodes per 1000 person years for children less than 5 years old was observed in the 
Netherlands (45), and even higher incidence data have been reported from Norway (129) and 
other high-in come countries in studies including all age groups (91,203,223). Diarrhoeal 
diseases therefore lead to many visits to physicians, hospital admissions and lost work time 
for parents as well as to considerable expenses both for families and the community (12,89).  
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Diarrhoea has been defined as passage of unusually loose or watery stools, usually at 
least three times in a 24 hour period (244). A change in consistency and character of the stools 
is recognized as more important than the number of stools. The above definition does not 
apply to breastfed babies where loose stools are normal. Therefore it is usually agreed that the 
assessment whether a child fed on breastmilk has diarrhoea or not preferably should be made 
by the mother or another person who knows the child. The term diarrhoea is actually a 
description of a symptom, which may be caused by infections of the gastrointestinal tract 
(also termed infectious gastroenteritis), by systemic infections and by non-infectious 
conditions (86). However, it is also commonly used, as in this paper, as a term for the disease 
gastrointestinal infection leading to diarrhoea, and not only the symptom (117).  
There are three main clinical types of diarrhoea; acute watery, persistent and bloody 
diarrhoea. Acute and persistent diarrhoea are not distinct diseases, but represent two ends of a 
continuum. Most episodes of acute diarrhoea resolve within seven days, but some persist 
beyond two, three and four weeks (140,207). The World Health Organization (WHO) and 
most investigators use a definition of persistent diarrhoea as diarrhoea lasting 14 days or 
longer (10). Although the 14 days limit is arbitrary, it is supported by an increased case 
fatality rate in children with diarrhoea of longer duration (5). Bloody diarrhoea is defined as 
diarrhoea with visible or microscopic blood in the stools, due to local mucosal damage and 
intestinal haemorrhage (117). A special form of bloody diarrhoea is the dysentery syndrome 
characterized by small-volume, bloody stools, abdominal cramps, and tenesmus, which is a 
severe pain in relation to straining to pass stools.  
Of these categories, acute watery diarrhoea is most common and accounts for 80% of 
all cases of childhood diarrhoea, and for 50% of the diarrhoea associated mortality (243,244). 
Persistent diarrhoea is less common and contributes to only 10% of all diarrhoeal episodes, 
but is associated with a disproportionately increased risk of death due to severe malnutrition. 
Worldwide, persistent diarrhoea has been estimated to be responsible for 35% all diarrhoeal 
deaths (243), but has in some studies from South Asia been found to be responsible for more 
than half the diarrhoeal deaths (16,118). Dysentery is seen in 10% of all cases of diarrhoea 
and causes 15% of the deaths (243).  
The intestinal physiology is altered by enteric infection principally in one of three 
ways: 1) changing water and electrolyte fluxes in the upper small bowel resulting in watery 
diarrhoea, 2) by inflammatory or cytotoxic destruction of the intestinal mucosa characterized 
by the presence of faecal leukocytes and dysentery, or 3) by microbial penetration through an 
intact mucosa to the reticuloendothelial system leading to enteric fever sometimes with only 
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mild diarrhoea [reviewed in (86)]. Most enteric agents alter the intestine in mainly one of the 
three mentioned ways. However, combinations of different mechanisms are not uncommon.  
A number of microorganisms, including a variety of viral, bacterial, and protozoan 
agents may cause diarrhoeal disease. The four most common viruses associated with acute 
gastroenteritis are rotavirus, norovirus, enteric adenovirus, and astrovirus (36). Bacterial 
diarrheagenic agents include Salmonella spp., Shigella spp., Yersinia enterocolitica, 
Campylobacter spp., and Vibrio spp., including Vibrio cholera, and different variants of 
Escherichia coli (5,86). In addition, enterotoxin producing variants of Bacillus cereus, 
Clostridium perfringens, and Staphylococcus aureus cause gastroenteritis. Clostridium 
difficile associated diarrhoea is commonly seen in relation to prolonged antibiotic therapy. 
Other species like Aeromonas spp. and Plesiomonas spp. may more rarely be responsible for 
diarrhoea symptoms. The two best known protozoan agents that may cause diarrhoea are 
Giardia lamblia, and Entamoeba histolytica, but Cryptosporidium parvum, Cyclospora 
cayetanensis, Isospora belli and microsporidia may also cause such disease. In addition, 
malabsorption, inflammatory bowel disease, irritable bowel syndrome and a wide range of 
other non-infectious conditions may result in diarrhoeal symptoms. 
Although some microbial agents are more common causes of diarrhoea than others, 
assessment of the relative contribution of each agent is difficult. This is partly due to 
considerable variation in the isolation of enteropathogenic agents with the population and the 
geographical area studied, but also to the fact that in the majority of studies the investigation 
is restricted to a limited group of microbial agents (75). In addition, no infectious causative 
agent is identified in up to half the cases even when an extended search for microbial agents is 
done, either due to the presence of unrecognized enteropathogens, or a non-infectious cause of 
the diarrhoea (20). 
 
1.2  Escherichia coli 
Escherichia coli was first described as Bacterium coli commune by the German paediatrician 
Theodore Escherich in 1885. This name was used until the genus Escherichia with the type 
species E. coli was defined by Castellani and Chalmers in 1919 [reviewed by Cheasty and 
Smith in (33)]. The E. coli species is a member of the family Enterobacteriaceae within the 
phylum Proteobacteria. It is a rod-shaped bacterium 2-6 μm long and 1.1-1.5 μm wide, which 
has rounded ends and is gram-negative. Strains belonging to this species can be cultured both 
aerobically and under anaerobic conditions, have simple nutritional requirements and do not 
form spores. They can be grown at temperatures up to 44°C, and have a generation time of 20 
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min. under optimal conditions. Most strains are motile. When tested biochemically E. coli are 
oxidase negative, catalase positive, ferment glucose, reduce nitrate, give a positive o-
nitrophenyl-β-galactopyranoside (ONPG) reaction, produce indole and fail to produce urea or 
H2S. They do also normally ferment lactose. Other species within the genus are E. blattae, E. 
fergusonii, E. hermannii, E. vulneris, and the recently proposed E. albertii.                                                       
E. coli is a commensal of the intestines of humans, mammals and birds where it 
constitutes the most prevalent facultative anaerobic species with 107 colony forming units 
(CFU) per gram faecal content (153). However, this species is present in much smaller 
numbers than anaerobic bacteria which make up more than 99% of the 1010-1011 
bacteria/gram in faeces (149,233). E. coli bacteria are excreted with the stools and may 
survive for some time outside the body, but do not normally have any independent existence 
in the environment (33). Accordingly, detection of E. coli is extensively used as an indicator 
of faecal contamination of water and food. 
In addition to its role as commensal, E. coli may cause various types of intestinal and 
extraintestinal infections. Of extraintestinal infections, urinary tract infections (UTIs), where 
E. coli is the single most prevalent pathogen, are among the most common infections both in 
the community and in hospitals (94,216). E. coli strains which cause UTIs often have specific 
virulence factors, while strains without such virulence factors, termed commensal strains, 
more rarely cause this type of infection. E. coli is also one of the most common infectious 
agents isolated from patients with bacteraemia and sepsis (63), and one of the leading causes 
of neonatal meningitis (43,120). In addition, commensal E. coli may cause infections in 
nearly any body site due to an aggravating factor such as a foreign body or host compromise 
(193). 
Virulence factors which makes certain strains of E. coli pathogenic may be classified 
in two groups according to function (109). One of these consists of colonization and fitness 
factors making the bacterium able to colonize and survive on the mucosal surface or, more 
rarely, to invade the host. The second group consists of toxins and effectors which may 
induce damage to the host. Some of the virulence factors do also help the bacterium evade the 
host immune defences. Depending on their virulence profile E. coli strains are classified in a 
number of extraintestinal (ExPEC) and diarrheagenic (DEC) pathotypes. 
Serotyping was for many years the only tool available to identify pathogenetic variants 
of E. coli. This method, established by Kauffmann in the 1940s, is based on heat-stable 
lipopolysaccharide O antigens and heat-labile flagellar H antigens. Kauffmann also described 
other heat-labile capsular K antigens [reviewed by Cheasty and Smith in (33)].  So far 174 O 
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serogroups and 53 H antigens have been described (84,205). Clinical microbiology 
laboratories have mainly used serogroup determination with the most common O antigens in 
the diagnosis of diarrheagenic E. coli. O:H serotyping requires a complete set of antisera as 
well as extensive experience, and is therefore done only in few international reference and 
research laboratories. 
Based on multilocus enzyme electrophoresis (MLEE), E. coli was classified in 
phylogenetic groups named A, B1, B2, D and E (208). Group E has later been used rarely due 
to the inconsistent clustering of this group (242). Based on the early MLEE studies it was 
believed that the E. coli population was largely clonal and that recombination was infrequent 
in this species (208). However, recently this statement has been questioned when homologous 
recombination was found to be common among commensal and pathogenetic E. coli strains 
analysed with multilocus sequence typing (MLST) (103,242). Wirth et al. did also show that 
that one third of the all strains in their study contained significant ancestry from multiple 
sources, and did therefore assign such strains to hybrid groups, named ADB and AxB1 (242). 
It was not possible to deduce a definite ancestral relationship among the major phylogenetic 
groups in that study. 
   
1.2.1  E. coli as diarrhoeal agent -historical perspective 
The capability of certain E. coli strains to cause diarrhoea was reported as early as 1887 
[reviewed by Clarke (37)]. However, only after Bray reported the isolation of E. coli from 
cases of summer diarrhoea in 1945 was more widespread interest in this organism as enteric 
pathogen evoked (27). Over the next three decades E. coli strains of certain serotypes (O111, 
O55 and O127) were frequently diagnosed as cause of childhood diarrhoea in industrialized 
countries [reviewed by Levine and Edelman (134)]. The term enteropathogenic E. coli 
(EPEC) was first introduced by Neter et al. in 1955 to describe E. coli strains that were 
epidemiologically implicated in infant diarrhoea (161). During this period mortality rates 
>50% were reported in diarrhoeal outbreaks among children attributed to EPEC. From around 
1960, for unknown reasons, both the incidence and lethality of EPEC declined in 
industrialized countries (157). In Norway, during this period EPEC was found to be common 
in children admitted to hospital, but was in most cases associated only with mild symptoms 
(72,130).  
The pathogenic potential of the E. coli serotypes most frequently isolated from 
children with diarrhoea was confirmed in several volunteer studies during the first half of the 
1950s [reviewed in (134)]. In addition, such strains were usually present in pure culture in 
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children with diarrhoea, compared to only in small numbers in healthy children. Infants with 
diarrhoea were also shown to develop a serologic response to the EPEC strain isolated from 
their stool (83,161,247). In addition to the most common EPEC serogroups mentioned above, 
several other O-serogroups and O:H serotypes were associated with infant diarrhoea, and 
were accordingly classified as classical EPEC serogroups and serotypes (134).  
During the 1960-70s, strains belonging to the classical EPEC serotypes were found to 
contain specific virulence factors (53,55,82,146,209). Strains with heat-labile and/or heat-
stable enterotoxins were named enterotoxigenic E. coli (ETEC), and invasive strains were 
named enteroinvasive E. coli (EIEC). When it was shown that these new virulence factors 
were present in only some of the strains belonging to the classical EPEC serogroups, the use 
of serotyping to identify diarrheagenic E. coli was seriously questioned. However, the 
pathogenicity of EPEC strains without any of these virulence factors was definitely verified 
by Levine et al. in human volunteer studies in 1978 (133). This finding brought about an 
intensive search for the pathogenetic mechanism of E. coli-induced diarrhoea. Diagnostic 
methods based on diarrhoea-causing traits seemed to be better than identification based solely 
on serotype. 
From the late 1970s rapid progress in the revelation of different phenotypic and 
genetic mechanisms linked to diarrhoeal disease lead to the identification of at least six 
pathotypes of diarrheagenic E. coli. In addition to the already known ETEC and EIEC 
pathotypes, enterohemorrhagic E. coli (EHEC), enteroaggregative E. coli (EAEC), diffusely 
enteroadherent E. coli (DAEC) and enteropathogenic E. coli (EPEC) were shown to have 
distinct phenotypic and/or genetic characteristics (109,157) (Fig. 1). Through these 
revelations the use of the name EPEC changed from meaning all E. coli associated with 
diarrhoea to the new specific EPEC pathotype.  
ETEC is primarily a pathogen of developing countries where it is a leading cause of 
weaning diarrhoea in infants [reviewed in (182)]. In addition, it is known as one of the major 
causes of traveller’s diarrhoea. ETEC bacteria colonize the surface of the small intestines by 
one or more different variants of fimbrial or fibrillar colonization factors (CFs) (230). 
Diarrhoea is induced by two classes of toxins, the heat-labile (LTs) and heat-stable (STs) 
enterotoxins which cause secretory diarrhoea  through  increased Cl--secretion (238). 
Although there are two variants of each enterotoxin, only ETEC strains with the LTI and STa 
variants are recognized human pathogens, while strains containing the variants LTII and STb 
are found mainly in animals. 
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(113,189). EHEC infections usually start as watery diarrhoea, and may progress to HC and 
HUS in some subjects. Diarrhoea-associated HUS is one of the most common causes of acute 
renal failure in otherwise healthy children (224). This syndrome is seen most often in children 
< 10 years of age. Case fatality rates up to 5% is seen in children with diarrhoea-associated 
HUS (210). The toxins responsible for cytotoxicity in Vero cell culture is closely related to 
the Shiga toxin of Shigella dysenteriae serotype 1 (169), and are divided in two major toxin 
families stx1 and stx2, with several variants in each group (168,195). All E. coli strains 
containing stx genes are termed verotoxigenic E. coli (VTEC), based on their Vero cell 
toxicity, or shiga toxin producing E. coli (STEC), based on the toxin type, while the term 
EHEC has been reserved for the subset of strains which are associated with human disease 
(157). Although the serotype O157:H7 has been associated with the most severe disease, 
shiga toxins have been detected in more than 200 E. coli serotypes (33). The majority of these 
serotypes are not associated with diarrhoeal disease in humans. EHEC strains usually contain 
a variety of virulence factors in addition to the stx. Some of these have been reported to be 
associated with severe EHEC disease (111,239). Among such virulence factors are the 
chromosomal pathogenicity island named the locus of enterocyte effacement (LEE), which 
enables intimate attachment of the bacterium to the intestinal epithelium, a large plasmid 
named pO157 containing several putative virulence genes including the haemolysin gene 
ehxA, and a variety of other virulence factors (109).  
EAEC has in recent years increasingly been recognized as a cause of acute and 
persistent diarrhoea in children and adults, and has also been reported to be one of the most 
frequent causes of traveller’s diarrhoea (95). Recognition of this pathotype was primarily 
based on the ability of EAEC bacteria to adhere to epithelial cells in cell culture in a 
characteristic “stacked-brick” pattern called aggregative adherence (158). The pathogenesis of 
EAEC infection is only partially revealed, but such bacteria have been shown to express 
enterotoxins and cytotoxins, and to elicit mild mucosal inflammation (155). EAEC strains 
appear to be heterogeneous and probably include both pathogenic and non-pathogenic clones 
(155). The pAA plasmid with the transcriptional regulator gene aggR have been associated 
with diarrhoea (102,196). Strains with this gene have therefore been termed typical EAEC, 
while strains lacking this gene have been classified as atypical EAEC (88). An interesting 
additional feature of the EAEC pathotype is the importance of host factors for the 
development of symptomatic disease. Jiang et al. showed that a certain nucleotide 
polymorphism in the IL-8 promoter was significantly associated with diarrhoea in US 
residents who were infected with EAEC during a travel to Mexico (102). 
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The DAEC pathotype is defined by the presence of a characteristic diffuse adherence 
pattern in cell culture (158). The pathogenicity of the DAEC pathotype is controversial as 
such strains are frequently isolated from subjects without diarrhoea. However, they have been 
associated with diarrhoeal disease in some studies, especially in children > 12 months of age 
(157,199). While the fimbrial adhesin F1845 is commonly present in DAEC strains (19), little 
is known about a pathogenetic mechanism for this pathotype. 
Other potential pathotypes have been suggested. One such pathotype is known as 
adherent-invasive E. coli (AIEC) which has been reported to be associated with Crohn’s 
disease (42). Strains belonging to this pathotype can invade and replicate within macrophages 
without inducing host cell death, and are able to induce release of high amounts of Tumor 
Necrosis Factor-alpha, possibly leading to intestinal inflammation. Two other putative 
pathotypes are the necrotoxic E. coli (NTEC) and the cell-detaching E.coli (CDEC). Both 
these pathotypes, defined by the presence of cytotoxic necrotizing factors (CNF1-2) and 
cytolethal distending toxins (CDT1-4), respectively, may infrequently be seen in subjects with 
diarrhoea (44,56). 
  
1.2.2  Enteropathogenic E. coli (EPEC) 
1.2.2.1  Pathogenetic mechanism 
EPEC is characterized by its ability to cause a characteristic intimate attachment to the 
intestinal epithelium (148). This type of attachment, termed an attaching and effacing (A/E) 
lesion, is similar to the adherence seen with many EHEC strains. It is, in addition to the 
characteristic intimate attachment, characterized by effacement of intestinal microvilli, 
formation of pedestal-like structures, and aggregation and concentration of actin filaments in 
the intestinal cell directly beneath the adherent bacteria (122) (Fig. 2). The genes necessary 
for attaching and effacing lesion formation are located on the chromosomal pathogenicity 
island called locus of enterocyte effacement (LEE) (142). The LEE of the prototype EPEC 
strain 2348/69 contains 41 open reading frames organized into five polycistronic operons 
(gene clusters transcribed into one mRNA), named LEE1, LEE2, LEE3, TIR and LEE4 (Fig. 
3) (57,145). Based on analyses of phylogenetic relationships and the site of insertion in the E. 
coli chromosome, there are three main types of the LEE region (104). However, the LEE may 
also be seen as a mosaic of genetic elements where the elements are differently affected by 
recombination and mutation (32).  
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 In addition to the above classifications, the LEE may be separated in three domains 
based on the function of genes (57,145); genes encoding intimate adherence, genes encoding 
proteins which are secreted from the bacterium, and genes encoding a type III secretion 
system. The first domain contains two genes essential for the ability of the bacterium to 
adhere intimately to the intestinal epithelial cell surface. Among these, the eae gene encodes a 
transmembrane protein, intimin, which functions as a ligand for epithelial cell adhesion 
(49,101). It also stimulates a systemic immune response, as demonstrated in a volunteer study 
(135), and intimin of the Citrobacter rodentium has been shown to induce mucosal Th1 
immune response and intestinal crypt hyperplasia in mice (93). The intimin protein consists of 
an N-terminal part inserted in the bacterial outer membrane, and an extracellular C-terminal 
domain involved in receptor recognition (114,137). Whereas the N-terminal part is conserved, 
considerable variation is seen in the C-terminal domain between different EPEC strains 
(66,67).  
At least five different antigenic variants of the intimin protein have been identified by 
serological methods (2,3,173). However, 21 different allelic variants of the eae gene encoding 
the intimin protein have been identified based on comparison of nucleotide sequences (21) 
(Fig. 4). The three most common intimin types alpha, beta and gamma have been reported to 
influence host specificity and tissue tropism using different animal in vivo and in vitro 
models, and human intestinal in vitro organ culture (62,76,152,179,231). These studies 
revealed that exchange by genetic manipulation of the intimin types alpha and gamma 
between EPEC and EHEC strains alters the tissue tropism according to intimin type. In 
contrast, substitution of EPEC intimin alpha and EHEC intimin gamma with the beta variant 
resulted in different tropism between the two strains indicating that other strain characteristics 
than intimin type are also of importance. However, since the results from the different 
experimental models are not necessarily exchangeable, comparison and interpretation of the 
results is difficult.  
The translocated intimin receptor (Tir), another LEE encoded protein, is transferred 
from the bacterium into the intestinal epithelial cell where it is inserted into the outer 
membrane and acts as a receptor for intimin (116). In addition, Tir has been reported to have 
signalling functions within the epithelial cell implicated in pedestal formation (107).  
The second functional domain of the LEE encodes several proteins which are secreted 
from the bacterium. Some of these proteins become part of the secretion apparatus (espA, 
espB and espD), while other (espF, espG, espH, Map and sepZ/espZ) are effector proteins 
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which are delivered into the epithelial cell where they interfere with a variety of cellular 
processes (46). 
The third and largest functional domain consists of about 20 highly conserved genes 
encoding the type III secretion system (TTSS). The TTSS forms a hollow needle structure 
which adheres (38,54) and establishes a transient link to the epithelial cell surface (123), 
through which effector proteins may be translocated to the interior of the host cell. After 
effector proteins have been transferred, the TTSS complex is removed to make possible 
intimate attachment between the bacterium and the epithelial cell surface through interaction 
between intimin and Tir (68,123). 
 Another important characteristic of EPEC is its ability to adhere to epithelial cells in 
discrete three-dimensional microcolonies, named localized adherence (LA) (202). This 
phenotypic trait is mediated by type IV fimbriae called bundle-forming pili (Bfp) (78). These 
are encoded by a cluster of genes, including bfpA which encodes the major structural subunit, 
located on the 50-70 MDa plasmid E. coli adherence plasmid (EAF) (225). This plasmid also 
Fig. 4. Dendrogram showing phylogenetic relationships between 21 different 
intimin variants (intimin variants are denoted with greek letters).The tree was 
contructed using the Clustal W program. Phylogenetic analysis revealed six 
groups of closely related intimin genes. Numbers on branches denotes genetic 
distance. Reprinted from reference (21) with permission  from the publisher. 
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contains transcriptional activator (per) genes shown to be involved in the regulation of the 
expression of the bfp genes as well as the chromosomal LEE genes (226,248).  
 A number of toxins, adhesins and factors with other functions encoded by genes 
located outside the LEE have also recently been linked with virulence in EPEC. Effector 
proteins encoded by such genes may be secreted through the LEE encoded the TTSS or via 
some other mechanism. A list of virulence factors with a description of their function is 
presented in Table 1. 
In addition to EPEC, the majority of EHEC strains [reviewed in reference (111)] and 
E. coli of several animal species contain the LEE and are capable of inducing A/E lesions. 
Animal pathogenic E. coli containing the LEE include the rabbit pathogenic E. coli (REPEC) 
(31) and the pork pathogenic E. coli (PEPEC) (249). Other bacterial species like the E. 
albertii (formerly subtype of Hafnia alvei) (98), and the mouse pathogen C. rodentium may 
also contain this virulence factor (204). 
Soon after the discovery of the pathogenetic mechanisms of EPEC it became clear that 
not all EPEC strains contained the EAF plasmid crucial for ability of the bacterium to cause 
localized adherence, and it was questioned whether such bacteria were true pathogens (157). 
At the Second International Symposium on EPEC in 1995 a consensus definition was reached 
(108). The EPEC pathotype was then divided in two types; strains which induced both 
attaching and effacing lesions and contained the EAF plasmid, were classified as typical 
EPEC, while attaching and effacing strains not containing the EAF plasmid were classified as 
atypical EPEC. Serotype characteristics were not part of the new definition, but many 
researchers still included in the new pathotype only strains belonging of the known EPEC 
serogroups (229). E. coli strains which contained the LEE, but did not belong to any of the 
EPEC serogroups, were sometimes referred to as attaching and effacing E. coli (A/E E. coli). 
Considerable heterogeneity has been reported among non-typical EPEC strains (80,229,236). 
EPEC is differentiated from the EHEC pathotype, which also usually contain the LEE 
and induce attaching and effacing lesions, by the presence of stx genes in strains of the latter 
pathotype (108). 
 
1.2.2.2  Mechanism of diarrhoea 
Although the pathogenetic mechanisms of EPEC infection have been unravelled to a great 
extent, the mechanism by which this organism induces diarrhoea is still unclear. This may be 
because several different mechanisms are involved. One such mechanism may be a dramatic 
loss of microvilli resulting in brush border enzyme deficiency and malabsorption (34). This 
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Table  1. Recognized or putative virulence factors in EPEC. 
 
Factor Description Function References 
Bfp Bundle forming pilus Causes localized adesion, Type IV pilus (79) 
Cif Cycle-inhibiting factor Blocks mitosis in cell cycle g2/M phase (141) 
EAST Heat stable enterotoxin Activates guanylate cyclase resulting in ion 
secretion 
(53) 
Efa1/lifA E. coli factor of adherence/ 
lymphycyte inhibiting factor 
Adhesin, inhibits lymphocyte activation (1,122,171) 
EspA E. coli secreted protein A Hollow tube structure essential for transferal 
of TTSS dependent effector proteins 
(74,126) 
EspB E. coli secreted protein B TTSS component involved in pore formation 
in the epithelial cell plasma membrane 
(74,100,246) 
EspC E. coli secreted protein C Serine protease, induces damage to host cell 
cytoskeleton 
(150,167) 
EspD E. coli secreted protein D TTSS component involved in posre formation 
in the epithelial cell plasma membrane 
(74,100,131) 
EspF E. coli secreted protein F Opens tight junctions, induces apoptosis (39,149) 
EspG E. coli secreted protein G Disrupts the microtubule network, alter 
epithelial cell permeability 
(143,212) 
EspG2 E. coli secreted protein G2 Disrupts the microtubule network, alter 
epithelial cell permeability 
(143,212) 
EspH E. coli secreted protein H Modulates filopodia and pedestal formation (211,231) 
EspI/nleA E. coli secreted protein I Effector protein, unknown function (87,157) 
EspJ E. coli secreted protein J Influences dynamics of clearence from the 
intestinal tract 
(41) 
EspZ/sepZ E. coli secreted protein Z Effector protein, unknown function (109) 
Flagellin Flagellin Induces cytokine expression through toll-like 
receptor type 5 (TLR5), may act as adhesin 
(46,80,253) 
Intimin Intimin Intimate adhesion, induces TH1 response (50,96,103,138) 
Lpf Long polar fimbriae Adhesin (169,229) 
LPS Lipopolysaccharide Induces cytokine expression through toll-like 
receptor 4 (TLR4) 
(111) 
Map Mitochondrial-associated 
protein 
Disrupts mitochondrial membrane potential (74,119) 
Paa Porcine attaching and 
effacing.associated factor 
Adhesin (10) 
NleB Non-LEE encoded effector 
protein B 
Unknown function, associated with virulence (47,117) 
NleC Non-LEE encoded effector 
protein C 
Unknown function (47) 
NleD Non-LEE encoded effector 
protein D 
Unknown function (47) 
NleE Non-LEE encoded effector 
protein E 
Unknown function (47) 
NleF Non-LEE encoded effector 
protein F 
Unknown function (47) 
Tccp/espFu Tir cytoskeleton-coupling 
protein 
Effector protein that couples Tir to the actin 
cytoskeleton 
(74) 
Tccp2 Tir cytoskeleton-coupling 
protein 2 
Effector protein that couples Tir to the actin 
cytoskeleton 
(177) 
Tir Translocated intimin receptor Nucleation of cytoskeletal proteins, loss of 
microvilli, GTPase-activating protein like 
activity 
(108,111,118) 
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mechanism cannot, however, explain the rapid onset of diarrhoea less than three hours after 
the ingestion of EPEC bacteria seen in volunteer studies (49). Another possible mechanism 
may be a direct effect of EPEC on the alteration of electrolyte transport across the epithelial 
cell membrane observed in vitro studies (41,217). A third mechanism may be an increase in 
epithelial permeability through disruption of tight junctions as the result from an intracellular 
signalling cascade within the host cell mediated by the EPEC effector protein EspF (143,144). 
Lastly, flagella from EPEC bacteria have also been shown to induce an inflammatory host 
reaction through increased IL-8 production which may cause tissue damage (197). However, 
whether this mechanism actually contributes to an inflammatory response in EPEC infections 
is controversial. EPEC bacteria have also been shown to inhibit IL-8 expression (46). 
 
1.2.2.3  Epidemiology 
Historically studies on epidemiology and clinical aspects of EPEC infections were based on 
the identification of EPEC serogroups (134), or, after 1980, on the detection of the EAF 
plasmid or localized adherence (157). Differentiation between typical and atypical EPEC is 
therefore usually not possible in studies performed before the 1990s when the distinction 
between the two EPEC subtypes was accepted in the scientific community (108). However, 
most of the EPEC strains detected in these studies were probably typical EPEC, and therefore 
epidemiological data from these studies are most likely representative for this EPEC subtype.  
As previously mentioned, EPEC used to cause frequent outbreaks with high case 
fatality rates in industrialized countries until the 1970s (134). From then on EPEC was rarely 
identified both in outbreaks and sporadic cases of diarrhoea (157). The latter may partly have 
been due to the fact that many laboratories stopped including EPEC in their test panel. In 
contrast, EPEC is still an important cause of childhood diarrhoea in low-income countries 
where it also in recent years has been a major cause of infant diarrhoea. The prevalence of 
typical and atypical EPEC among children with diarrhoea reported in studies from many 
different countries are presented in Table 2. Interestingly, there are considerable differences in 
the frequency of isolation of EPEC from children with diarrhoea between different countries, 
and even within the same country. This may be caused by differences in the patient selection 
and the diagnostic methods used, but is probably also due to actual geographic differences in 
EPEC epidemiology. Interestingly, a decline in the role of EPEC similar to that seen in 
industrialized countries some decades ago was recently reported from Brazil (191). 
Case-control studies from many countries have shown that EPEC primarily causes 
disease in children less than two years of age [reviewed in (134,157)]. The correlation  
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Table 2. Prevalence of typical and atypical EPEC in children with diarrhoea from different 
countries reported in recent years. Data compiled from published reports by the author. 
Author Year Country No. 
Typical EPEC 
no. (%)a 
Atypical EPEC
no. (%)a 
Escheverria et al. (55) 1991 Thailand 509 30 (5.9) 5 (1.0) 
Gomez et al. (81) 1991 Brazil 500 137 (27.4) 32 (6.4) 
Morelli et al. (150) 1994 Italy 112 2 (1.8) - 
Albert et al. (7) 1995 Bangladesh 451 70 (15.5) 0 
Forestier et al. (64) 1996 France 220 3 (1.0) 12 (5.5) 
Bokete et al. (23) 1997 USA 445 3 (0.7) 17 (3.8) 
Scaletsky et al. (201) 1999 Brazil 40 9 (22.5) 7 (17.5) 
Gascon et al. (74) 2000 Tanzania 103 4 (3.9) c - 
Okeke et al. (170) 2000 Nigeria 187 4 (2.1) c - 
Galane et al. (70) 2001 South Africa 151 6 (4.0) 48 (31.7) 
Knutton et al. (124) 2001 UK 1496 6 (0.4) 112 (7.5) 
Scaletsky et al. (198) 2002 Brazil 237 21 (8.9)  13 (5.5) 
Scaletsky et al. (200) 2002 Brazil 100 17 (17.0) 6 (6.0) 
Dulguer et al. (52) 2003 Brazil 438 45 (10.3) 38 (8.7) 
Nunes et al. (167) 2003 Brazil 125 14 (11.2) 11 (8.8) 
Presterl et al. (181) 2003 Gabon 150 0 0 
Ratchtrachenchai et al. (185) 2004 Thailand 2100 61 (2.9) 24 (1.1) 
Regua-Mangia et al. (186) 2004 Brazil 199 5 (2.5) 11 (5.5) 
Robbins-Browne et al. (190) 2004 Australia 696 2 (0.3) 89 (12.8) 
Nguyen et al. (164) 2005 Vietnam 587 0 39 (6.6) 
Rappelli et al. (184) 2005 Mozambique 548 7 (1.3)d 9 (1.6)d 
Cohen et al. (40) 2005 USA 684 -(0.4) - (6.5) 
Olesen et al. (171) 2005 Denmark  396 7 (2.0) 44 (11.0) 
Orlandi et al. (172) 2006 Brazil 470 10 (2.1) 19 (4.0) 
Nataro et al. (159) 2006 USA 317 2 (0.2)e 20 (6.3) 
Prere et al. (180) 2006 France 280 30 (10.7) c - 
Nguyen et al. (163) 2006 Australia 134 0 30 (22.4) 
Vernacchio et al. (234) 2006 USA 442 0 57 (12.9) 
Alikhani et al. (8) 2006 Iran 247 35 (14.2) 23 (9.3) 
Hien et al. (92) 2007 Vietnam 111 2 (0.9) 5 (4.5) 
a Numbers presented in the table are calculated from available information if not explicitly given in the referred 
study.  
b Only methods used for the identification of, and differentiation between, typical and atypical EPEC are listed 
c Includes both typical and atypical EPEC  
d Three of 16 EPEC strains were isolated from healthy children 
e Typical EPEC strains isolated from patients of all ages  
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between EPEC infection and diarrhoea has been shown to be strongest for infants < 6 months 
old, while EPEC is frequently present without causing symptoms among children older than 6 
months to 2 years (134).  
The incubation period and infectious dose necessary to cause naturally transmitted 
EPEC diarrhoea is not known. In adult volunteer studies incubation periods of 7-16 hrs have 
been most common (47). However, this may not be representative for the incubation period  
for infants due both to differences in the intestine as well as different inoculum sizes in 
experimental compared to natural infections. Only high inocula (108-109 CFU) causes  
diarrhoea in adults volunteers (17,133,135) while probably considerably lower doses is 
needed to cause disease in infants. 
 Transmission of EPEC is predominantly through person to person spread via the 
faecal-oral route (134). However, food and waterborne transmission have been identified in 
EPEC outbreaks in adults (157,194,246), and even airborne transmission was suggested as a 
potential route of EPEC infection since it was isolated from dust and aerosols in one study 
(192). Many studies have documented spread of infection from index cases in hospitals, 
nurseries and day care centres (25,134,245).  
The primary reservoir of EPEC belonging to classical serogroups is believed to be 
children with EPEC diarrhoea, as well as asymptomatic children and adults (134). Attaching 
and effacing E. coli not belonging to EPEC serogroups, however, have been detected in many 
animal and bird species (126). 
 
1.2.2.4  Clinical features of EPEC infection 
EPEC most commonly causes acute diarrhoea (134,157). It is often accompanied by vomiting 
and low-grade fever. Many investigators have reported EPEC to cause severe diarrhoea with a 
high case fatality rate (47,134). In one study from Brazil 51% of the children infected with 
EPEC were dehydrated (81). However, this organism may also cause persistent diarrhoea 
(47,134). Fagundes–Neto et al. found that more than one fourth of the children admitted to 
hospital with EPEC infection had diarrhoea that lasted more than 14 days (60). EPEC 
infection does not cause bloody diarrhoea, but faecal leucocytes may occasionally be seen.  
 
1.2.2.5  Diagnosis  
For many years the diagnosis of EPEC was based solely on the identification of O serogroups, 
or O:H serotypes (134). Slide agglutination with polyvalent O antisera has been used for the 
diagnosis of EPEC by many laboratories. However, since EPEC O serogroups also contain 
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commensal E. coli strains, it has been estimated that only 10-25% of strains agglutinated by 
EPEC O antisera actually do belong to a recognized EPEC O:H serotype (134). Positive 
results may also be due to cross reactions between several of the O antigens. Complete 
serotyping for all 174 O serogroups and 53 H types would improve the diagnostic accuracy, 
but would be very laborious and is therefore done only for research purposes in few 
international reference laboratories. After the pathogenetic mechanism of EPEC diarrhoea 
was revealed, new phenotypic and genotypic diagnostic tests were developed.  
The diagnosis of EPEC should be based on the characteristics that define this 
pathotype (108): 1) bacterial strain confirmed as E. coli species, 2) the ability of the strains to 
cause attaching and effacing lesions, and 3) localized adherence, and 4) the absence of shiga 
toxins. This may be achieved by phenotypic and/ or genotypic tests. 
Phenotypic tests. Identification of the bacterial strain as E. coli may be done by a 
variety of biochemical methods. The attaching and effacing phenotype may be demonstrated 
by the fluorescent actin staining (FAS) test originally described by Knutton et al. (121). This 
test is designed to visualize aggregated filamentous actin in the epithelial cell immediately 
below intimately adherent EPEC bacteria. The bacterial strain is incubated in a HEp-2 or 
HeLa cell culture for 3 to 6 hours. After permeabilization and repeated washing, the cells are 
stained using the mushroom toxin phalloidin conjugated to fluorescein isothiocyanate (FITC). 
The specimens are then examined under a fluorescence microscope as well as in phase-
contrast microscopy. Spots of fluorescence corresponding to the location of bacterial cells 
visualize actin aggregation and are recorded as a positive FAS test. The attaching and effacing 
phenotype may also be visualized by electron microscopy.  
Localized adherence, which is used to differentiate between typical and atypical 
EPEC, is demonstrated in HeLa or HEp-2 cell culture performed as described above, but 
strained with Giemsa and examined by light microscopy (48). An ELISA test has also been 
developed which was shown to be specific for EAF containing EPEC strains (6).  
Phenotypic tests to differentiate EPEC from the shiga toxin-containing EHEC 
pathotype, includes detection of cytotoxicity in Vero cell culture and immunoassays 
(176,213). 
 Genotypic methods. Genotypic methods can be used to identify the presence of genes 
essential for the attaching and effacing phenotype (usually the eae gene) and localized 
adherence (EAF plasmid or bundle forming pilus genes), and the absence of genes encoding 
shiga toxins (stx1 and stx2). Both DNA probes and a variety of PCR primers and protocols 
have been developed for the diagnosis and characterization of genes important for each of 
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these traits. Whereas hybridization methods generally are cheaper than PCR, the latter method 
enables a rapid identification of EPEC from clinical specimens. 
 The eae gene is usually chosen as target for the primary diagnosis of EPEC (157). The 
first genotypic eae test was based on a 1-kb fragment probe used in a hybridization assay 
developed by Jerse et al. (101). Later a variety of PCRs, both conventional  (71,110,136,240) 
and real-time PCR (141,166,188), have been developed for the conserved 5’ end of the eae 
gene. Several multiplex PCRs have also been designed with a combination of primers for the 
eae gene and other genes specific for other diarrheagenic E. coli pathotypes (26,178). 
Recently it was suggested to use the gene escV, encoding the E. coli secreted protein V, 
instead of the eae for the detection of the LEE since this gene has been shown to be the most 
conserved gene on the LEE pathogenicity island (151). 
 The first genotypic method for the detection of the EAF plasmid was a 1-kb fragment 
probe described by Nataro et al. (156). A specific oligonucleotide probe (100) and PCR (65), 
for the same probe sequence were also developed. Later a DNA probe (77) and a PCR 
targeting the bundle forming pilus gene bfpA (87) were developed and used either in stead of,  
or together with, methods targeting the initial EAF probe sequence. In general, there is 
excellent correlation between the genotypic methods and localized adherence in cell culture 
(198). Rarely, however, EAF probe negative strains may show localized adherence (23), 
possibly due to the presence of other virulence factors, and certain EAF positive strains may 
fail to induce localized adherence, due to a deletion in the bfpA operon (24). 
 Genotyping for the differentiation between the EPEC and EHEC pathotypes was first 
based on the detection of the stx1 and stx2 toxin genes by DNA probes (241). Later various 
variants of the PCR method have been developed and used for the same purpose (157). Due to 
sequence variation between the different variants of the stx2 gene, not all primer pairs 
designed for stx2 will detect all variants of this gene (183). In recent years real-time PCR 
methods (188), and multiplex PCR methods designed to detect all diarrheagenic pathotypes, 
have been developed, as mentioned above. 
 PCR detection of EPEC directly in stool samples is possible, but may be problematic 
due to inhibitory factors resulting in poor sensitivity (157). These problems are avoided when 
PCR is done on bacterial culture either on solid medium or in broth. However, an overnight 
culture step causes a delay of the result which is a disadvantage of this method. 
 
1.2.2.6  Treatment 
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Most children recover completely from EPEC diarrhoea if dehydration and electrolyte balance 
are corrected in time (37). Early feeding is recommended to avoid weight loss (244). In some 
cases, especially with persistent diarrhoea, parenteral nutrition is necessary due to extensive 
malabsorption (47). Antibiotics are not generally recommended by the WHO in the treatment 
of diarrhoea (244), but are sometimes used in severe protracted EPEC diarrhoea. Few studies 
have investigated the role of antimicrobial therapy for EPEC diarrhoea. Agents that have been 
reported to reduce the duration of diarrhoea are trimethoprim-sulfamethoxazole and 
mecillinam (47). Rifaximin, a rifampin-like antimicrobial agent, was also recently reported to 
limit the course of bacterial diarrhoea, often caused by EPEC, to 1-2 days (58). No effect on 
the course of diarrhoeal disease was observed in a recent study where oral polymyxin was 
compared with placebo in infants with severe diarrhoea (219). Differences in outcome 
between various studies may be due to the antimicrobial agent used, antimicrobial 
susceptibility of the causative bacterial strain, and differences between patient groups and in 
disease severity. Other therapies like bismuth subsalicylate and specific bovine anti-E. coli 
milk immunoglobulin have also proven useful in isolated studies (61,147). So far, there are no 
EPEC specific vaccines available although extensive research has been carried out in this 
field. 
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2  Aims of the studies 
 
Principal objective: 
The main aim of the study was to investigate the role of EPEC in diarrhoea among 
children in Norway. 
 
Specific aims: 
1. To investigate the prevalence of EPEC in children with infectious diarrhoea 
2. To investigate whether EPEC is epidemiologically associated with diarrhoea 
3. To compare EPEC strains with phenotypic and genotypic methods  
4. To search for genetic characteristics in EPEC strains epidemiologically linked with 
diarrhoea 
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3  Materials and Methods 
3.1  Study area 
The study was conducted in the County of Sør-Trøndelag situated in the central part of 
Norway with a total population of 268 000 inhabitants as of January 2003 (11), among whom 
6.5% were less than five years old (9). More than half the population (152 700 inhabitants) 
live in the city of Trondheim (11). The Department of Medical Microbiology, St. Olavs 
Hospital, Trondheim, is responsible for all microbiological analyses of human clinical 
specimens from Sør-Trøndelag. 
 
3.2  Study population 
The first study (Paper I) was a retrospective analysis of etiological agents in children less than 
2 years of age with diarrhoea from whom the laboratory had received a faecal specimen 
during the year 2001. In the subsequent case-control study (Paper II) the age range was 
extended to children less than five years old. In that study cases were children with suspected 
infectious gastroenteritis from whom the laboratory received a stool specimen, while controls 
were healthy children recruited through Maternal and Child Health Centres.  
 
3.3  Clinical information 
In the retrospective study information on the duration of diarrhoea was collected from 
hospital records and the referral forms (Paper I). In the case-control study demographic data 
and information on possible risk factors for gastrointestinal infection, medical history, and 
duration of disease was collected in a questionnaire as well as from the physician’s referral 
form. Information about hospital admission and discharge diagnosis was collected from 
hospital records (Paper I), referral forms and a questionnaire (Papers II-IV). 
 
3.4  Identification of EPEC 
EPEC was primarily diagnosed by PCR analysis of the eae gene on a streak from solid agar 
culture of faecal specimens. The PCR was done using published primers designed for the 
conserved part of the gene (71), with reagents as described below (see 3.7 Genotypic 
characterization of EPEC strains), and the following cycling conditions: 94ºC for 15 min, then 
denaturation at 94ºC (1 min), annealing at 60ºC (1 min), and extension at 72ºC (2 min) for 35 
cycles. Thereafter the mixture was held at 72ºC for seven min until cooling, and analysed with 
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2% agarose gel electrophoresis after staining with ethidium bromide. PCR for the stx1/stx2 
genes to differentiate EPEC from EHEC was done as previously described (28). eae and/ or 
stx positive isolates were identified by subculture and retesting of four (Paper I) or ten distinct 
colonies (Paper II) from primary PCR-positive cultures. Bacterial isolates that were eae 
positive, stx negative, and were confirmed biochemically to be E. coli (Api10S/ 20E, 
BioMerieux, France), were classified as EPEC. EPEC isolates were further analysed for the 
presence of the EAF plasmid gene bfpA. Based on the results of bfpA PCR (87), the isolates 
were classified as typical (bfpA positive) or atypical (bfpA negative) EPEC. 
Follow-up specimens were analysed by PCR for the eae gene on primary mixed 
culture without further subculture of positive specimens (Paper II). 
 
3.5  Diagnosis of other enteropathogenic agents - microbiological methods 
All specimens from children with diarrhoea were analysed for the bacterial enteropathogens 
Salmonella spp., Shigella spp., Yersinia spp., Areomonas spp., and Plesiomonas spp. using 
lycine saccharose-urea agar (106), SSI- enteric medium (22), and selenite broth (Difco, 
Maryland, USA). For the isolation of Campylobacter spp., specimens were cultured on 
charcoal cefoperazone desoxycholate agar (Mast Diagnostics, Merseyside, UK) (Paper I and 
II). In addition, specimens from patients with clinical information of bloody diarrhoea were 
cultured on Sorbitol-MacConkey (SMAC) agar. Identification of bacterial pathogens was 
done by standard microbiological methods.  
The specimens were examined for rotavirus with enzyme immunoassay 
(DakoCytomation, UK), and for adenovirus by enzyme immunoassay (DakoCytomation), 
PCR (127) and viral cell culture. Stool specimens containing eae positive isolates from 
children with diarrhoea in the case-control study were additionally tested for the presence of 
other diarrheagenic E. coli pathotypes (ETEC, EIEC and EAEC) by PCR (Paper II). These 
specimens were also examined with enzyme immunoassay for astrovirus and norovirus 
(DakoCytomation), Giardia lamblia (Remel), and Cryptosporidium (Cellabs). Stool 
specimens from control subjects were tested only for EPEC (Paper II). 
 
3.6  Phenotypic characterization of EPEC strains 
Serotyping. Bacterial growth of stool specimens on MacConkey agar was primarily tested for 
EPEC serogroups with the polyspecific O-antisera Anti-Coli I and Anti-Coli II (Sifin, ). E. 
coli strains which agglutinated with polyspecific antisera were further tested using 
monospecific O:K antisera at the Norwegian Institute of Public Health, Oslo (Sifin and in-
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house antisera). Later, all atypical EPEC strains were analysed for somatic (O) antigens 
(serogroups O1-O177) and flaggelar (H) antigens using standard methods (84,205) at the 
Escherichia, Shigella, Yersinia & Vibrio Reference Unit, Laboratory for Enteric Pathogens at 
the Health Protection Agency, London, UK. 
 EHEC immunoassay. Phenotypic analysis for shiga toxin I/II production was done 
using immunoassay (Premier EHEC, Meridan Bioscience, Cincinnati, USA) (Paper IV). 
 
3.7  Genotypic characterization of EPEC strains 
PCR. In addition to the use in the primary diagnosis of EPEC described above, PCR was used 
for the analysis of putative virulence genes not included in the microarray panel (Paper III and 
IV), to control the results of the microarray experiments for selected genes or gene variants 
(Paper III), and to differentiate between complete and truncated genes (Paper III). The PCR 
method was also used for amplification of housekeeping gene loci in the MLST analysis (see 
later, Paper IV). 
 All analyses were done by conventional PCR using primers and amplification 
conditions as described by other investigators, except for the genes nleB, nleD, nleC, nleE and 
nleF. For each of these genes a PCR method was developed for this study (Paper III). PCR 
amplification was then performed in a total volume of 50 µl, containing 50 µM (each) dATP, 
dCTP, dGTP, and dTTP, 0.5 µM each primer, 10x PCR buffer (Applied Biosystems, 
Branchburg, N.J.), 1.5 mM MgCl2, 1 U AmpliTaq Gold polymerase (Applied Biosystems), 
and 2 µl bacterial DNA extract as template. After the polymerase enzyme was activated by 
heating at 94°C for 15 min, amplification was carried out with the following conditions: 
denaturation at 94°C (1 min.), annealing at 53°C (1 min.), and extension at 72°C (1 min.) for 
35 cycles. Thereafter the mixture was held at 72°C for 7 min. before cooling to 10°C. 
Amplified products were analysed by agarose gel electrophoresis as described earlier. 
PFGE. Macrorestriction analysis (PFGE) was done to rule out that the EPEC strains 
were part of any unrecognized outbreak. Bacterial chromosomal DNA was digested with XbaI 
before separation by electrophoresis using the CHEF XA Mapper (Bio-Rad. Richmond, CA, 
USA) with the following electrophoretic conditions: 14 °C, linear ramp of 5–60 s over 24 h, 
120° switch angle and a gradient of 6.0 V cm-1(Paper I and IV). DNA fragments were stained 
by ethidium bromide and photographed under ultraviolet illumination. Image capturing was 
done by Gel Doc 2000 (Bio-Rad). 
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DNA oligonucleotide microarray. DNA microarray analysis was done to search for 
virulence genes possibly associated with diarrhoea among a broad range of known and 
putative E. coli virulence genes (Paper III). For this purpose a DNA oligonucleotide 
microarray developed by Bruant et al. was used (29). The version of the microarray used in 
our study was composed of 242 70-mer oligonucleotide probes specific for 182 virulence 
genes, or gene variants, from all known pathotypes of E. coli. Genomic DNA was 
fluorescently labeled with Cy5 with a random-priming protocol derived from the Invitrogen’s 
Bioprime® DNA Labeling System (Invitrogen life technologies, Burlington, Ontario) before 
hybridization was carried out at 50ºC, and scanned with a ScanArray® Lite fluorescent 
microarray analysis system (Canberra-Packard Canada, Montreal, Quebec).   
MLST. This method was applied to characterize the phylogenetic relationship between 
the atypical EPEC strains from the case-control study (Paper IV). For each strain the seven 
housekeeping genes adk, fumC, gyrB, icd, mdh, purA and recA were amplified and sequenced 
according to the protocol of the Esherichia coli MLST database (http://web.mpiib-
berlin.mpg.de ). PCR amplification of the seven gene loci was carried out with primers as 
previously published (242), sequenced with the PCR primer set, primers published by Tartof 
et al. (220), or with primers designed in this study: gyrB(Trh) F, icd(Trh) F, icd(Trh) R, and 
purA(Trh) R (Paper IV). The latter primers were designed due to unsatisfactory results of 
sequencing using available primers. Sequencing was performed using either the CEQ DTCS- 
Quick Star Kit (Beckman Coulter, Fullerton, California, USA) or the Big Dye terminator 
Cycle Sequencing Kit v 3.1 (Applied Biosystems) with subsequent capillary electrophoresis, 
respectively, on a Beckman Coulter CEQ 8800 or an ABI 3130x Genetic Analyzer. The 
sequence traces for each of the seven gene loci were assigned an allele number, and each 
strain was assigned a sequence type (ST) according to allelic profile, by submission of the 
sequences to the E. coli MLST database. 
 Methods for genetic comparison of EPEC strains. PFGE fragments were compared 
both by manual inspection (222) and by cluster analysis. Similarities of fragments between 
strains were compared using the Dice coefficient, and a dendrogram was constructed using 
the unweighted pair group method with arithmetic mean (UPGMA) clustering method using 
either the Fingerprinting II software (Bio-Rad)( Paper I) or the Bionumerics software (version 
4.6, Applied Maths, Sint-Martens-Latem, Belgium ). Significant clusters were determined by 
the point-bisectional correlation method (Bionumerics manual, version 4.6) (Paper IV). The 
EPEC strains were characterized in virulence clusters (Paper IV) using principal component 
analysis (Bionumerics) of all the detected virulence genes, gene variants and markers 
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identified in the microarray study. EPEC strains were assigned to a phylogenetic group 
according to its content of the three genes chuA, yjaA and tspE4C2 as proposed by Clermont 
et al. (39). Concatenated DNA sequences from the seven gene loci used for MLST analysis 
were aligned using the ClustalW algorithm of the MEGA3 software (128). A rooted 
Neighbour-joining tree was constructed using the Kimura 2-parameter model of nucleotide 
substitution. Phylogenetic network analysis was performed using the Neighbour-net algorithm 
and untransformed distances (p distance) of SplitsTree 4 (97). Evidence of recombination was 
assessed using the SplitsTree φw recombination test of the SplitsTree software. Assignations 
of STs in ST complexes were done by the curator of the E. coli MLST database using the 
MSTree application of Bionumerics. Finally, the Simpson’s index of diversity (96,211) was 
used to compare  phylogenetic diversity between EPEC strains. 
 
3.8  Ethical issues 
The study was reported to the Norwegian Social Science Data Services, and was approved by 
the Regional Committee for Medical Research Ethics, and the Norwegian Data Inspectorate.  
 
3.9  Statistical analyses 
The Chi-square or Fischer’s exact tests were used for comparison of differences between 
groups of nominal data. In the case-control study multiple logistic regression was used to 
study the potential association between EPEC and diarrhoea. The analyses were adjusted for 
matching factors (sex, age group, and time of specimen collection), and were controlled for 
potential confounding from other risk factors. The data were also analysed by conditional 
logistic regression. The Mann-Whitney U test was employed for testing of ordinal variables 
and quantitative data which were not normally distributed. A P-value < 0.05 was considered 
significant.  
The statistical analyses were mostly performed using SPSS (SPSS Inc, Illinois, USA). 
In addition, Stata version 8.0 (StataCorp 2003, Texas, USA) was used for the conditional 
logistic regression analyses (Paper II), and the R software package (version R2.1.1, 
http://www.r-project.org/) was used for the analyses of association between virulence genes 
and diarrhoea (Paper III). 
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4  Results 
4.1  Paper I 
Potential enteric pathogens were identified in 124 (28.2 %) of 440 children < 2 years of age 
with diarrhoea. EPEC was the most frequently identified agent in the study, and was isolated 
from 44 (10%) of the 440 patients. One of the eae-positive E. coli isolates was classified as 
typical EPEC (bfpA positive), while 43 isolates were classified as atypical EPEC (bfpA 
negative). Eight (18.6%) of 43 atypical EPEC isolates belonged to EPEC serogroups, while 
35 strains were not agglutinated by EPEC antisera. EPEC was detected in four (3.0%) of 135 
children admitted to hospital. None of these had severe acute gastroenteritis. Protracted 
diarrhoea was recorded for 12 (31.6%) of 38 patients with atypical EPEC infection. There was 
a considerable genetic diversity in PFGE patterns among the EPEC isolates, and each isolate 
displayed a unique pattern. EPEC was more common in children 12-23 months old (33/206 
patients, 16%) than in children < 12 months of age (11/234 patients, 4.7%; P<0.001). 
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4.2  Paper II 
In this case-control study EPEC was isolated from 38 (15.1%) of 251 children < 5 years old 
with diarrhoea. EPEC was detected in 21 (10%) of 210 healthy children < 5 years old. One 
isolate was classified as typical EPEC while 58 isolates were classified as atypical. EPEC was 
a less frequent finding in children < 1 year of age (6 isolates/148 children, 4.1%) than in older 
children (52 isolates/313 children, 17.6%). Four isolates, all from patients, belonged to EPEC 
serogroups. EPEC was found in 3 (5.1%) of 59 children who were admitted to hospital. 
Atypical EPEC was more commonly diagnosed in patients (37/251, 14.7%) than in controls 
(21/210, 10%), but the association with diarrhoea was not significant (OR=1.4, P=0.3). The 
prevalence of atypical EPEC was higher in children with prolonged diarrhoea (20/89, 22.5%) 
than in healthy children (21/210, 10%, OR= 2.1, P=0.04). Atypical EPEC was found in pure 
culture in 17 of 37 (45.9%) children with diarrhoea and in 5 of 21 (23.8%) controls (P=0.3). 
Ten of 30 (33.3%) patients and 4 of 20 (20%) healthy controls who submitted a follow-up 
specimen, did still have EPEC in their stools after a median of 38 and 59 days, respectively.  
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4.3  Paper III 
A total of 95 putative virulence genes or gene variants were detected in the 57 atypical EPEC 
strains included in this study. Seven genes were positively statistically associated with 
diarrhoea (Table 5). These were the OI-122 genes efa1/lifA (P=0.0002), set/ent, nleB and nleE 
(all with P=0.0006), the paa (P=0.01), the lpfAO113 (P=0.02), ehxA (P=0.04) and ureD 
(P=0.05). In addition the lpfA was significantly associated with diarrhoeal disease when all 
three variants of the gene were analysed together (P=0.0008). A significant negative 
association with diarrhoea was shown for the phylogenetic marker gene yjaA (P=0.0004), as 
well as for the astA (P=0.02), b1121 (P=0.02) and ibeA (P=0.05) genes. All except one of the 
atypical EPEC strains could be classified in one of two main virulence groups based on their 
content of OI-122 genes, and lpfA and yjaA genes: group I strains were defined by the 
presence of OI-122 genes and/ or lpfA genes, as well as the absence of the yjaA gene, while 
group II strains were defined by the presence of the yjaA gene and the absence of OI-122 and 
lpfA genes. Twenty four (64.9%) of 37 atypical EPEC isolates from children with diarrhoea 
belonged to virulence group I, while only 3 (15.8) of 19 isolates from healthy children 
belonged to the same group (P<0.001). In contrast, virulence group II strains were more 
commonly detected in healthy children (16/19 subjects, 84.2%) than in those with diarrhoea 
(13/37 subjects, 35.1%). Among children with diarrhoea, virulence group I strains were 
present both in those with acute (8 subjects) and prolonged diarrhoea (10 subjects) (Table 6). 
In contrast, virulence group II strains were mainly isolated from patients with protracted 
diarrhoea (10 subjects), and rarely from children with diarrhoea of short duration. Among 
children who submitted follow-up specimens, 12 (66.7%) of 18 subjects with virulence group 
II strains still had EPEC on follow-up, compared 3 (18.8%) of 16 subjects infected with group 
I strains (P=0.005). 
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4.4  Paper IV  
Among the 56 atypical EPEC strains included in this study 10 strains belonged to 
phylogenetic group A, 16 to group B1, 24 to group B2, and 6 strains to group D. Twenty six 
different STs and 20 different clonal groups were represented in the study. Phylogenetic 
analysis revealed evidence of phylogenetic incompatibility in the divergence of the atypical 
EPEC clones, and significant evidence of recombinational events (P=6.8x10-6). The strains 
were separated in three clusters by overall virulence gene profile: one large cluster included 
all phylogenetic group A, B1 and D strains, and two clusters consisted exclusively of group 
B2 strains (labeled B2-A and B2-B). Thirty one of the genes or gene variants observed in at 
least five bacterial strains were restricted to strains of one virulence cluster or phylogenetic 
group. Eleven different variants of the pathogenicity island LEE was present among the 
atypical EPEC strains when they were classified by their content of different variants of the 
espA, espB, tir and eae genes. Pathogenicity island OI-122 genes were present in strains 
belonging to 12 different STs, and the lpfA gene variants in 14 different STs, but only within 
the three phylogenetic groups A, B1 and D. The presence of the OI-122 genes was linked with 
LEE type. Genes related to the EHEC pathotype were detected in 14 (25%) of the atypical 
EPEC strains, all within the phylogenetic groups A, B1 and D. There was considerable 
heterogeneity in PFGE profiles and serotypes, and almost half the strains were O non-typable. 
The two phylogenetic groups B1 and D were weakly associated with diarrhoea (P=0.06 and 
P=0.09, respectively), while group B2 was isolated most frequently from healthy controls 
(P=0.05). 
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5  General discussion 
Having demonstrated that EPEC was a frequent finding in children with diarrhoea, a case-
control study was conducted to investigate the role of EPEC as a diarrheagenic agent (Paper 
II). To further clarify this issue, isolates collected in the case-control study were characterized 
with phenotypic and genetic methods (Papers III and IV).  
 
5.1  Identification and classification of EPEC strains 
It is difficult to design PCR primers which detect all variants of the eae gene due to sequence 
heterogeneity between different variants of the gene. The variability is most extensive in the 
3´ region of the gene, but there is also some degree of heterogeneity between different 
variants of the conserved 5´ region (157). In this study EPEC strains were primarily identified 
by a PCR with primers designed for the conserved region of the gene (71). The demonstration 
of eight different variants of the eae gene in the EPEC strains in this study shows that the 
PCR used was able to amplify many different variants of the gene, including the variants most 
frequently occurring in EPEC strains (21). However, sequence comparison with all published 
variants of the eae gene reveals polymorphisms in the target sequence for the PCR primers in 
some variants of the gene (BLAST searches, data not shown). It is therefore possible that the 
PCR may give a false negative result with EPEC strains with certain variants of the eae gene. 
This is, however, unlikely to represent a major issue since the PCR method covers all the six 
main variants of the eae gene (21)(Fig. 4). 
At the Second International EPEC Symposium in 1995 it was agreed that the 
classification of EPEC as typical or atypical should be based on the newly discovered 
pathogenetic mechanisms (108). EPEC strains were classified as typical EPEC if they 
contained the EAF plasmid encoding localized adherence and atypical EPEC if they did not 
contain this plasmid. Data regarding the serogroup or serotype of the EPEC strain was not 
included in the classification agreed at the meeting, although it was recognized that the 
majority of EPEC strains belonged to well-recognized O:H serotypes. Despite the agreed 
classification, however, many authors have restricted the label atypical EPEC to strains 
belonging to recognized EPEC serogroups, and have placed attaching and effacing strains not 
belonging to EPEC serogroups in a separate group, termed attaching and effacing E. coli 
(A/EEC) (229). The reason for this differentiation based on serogroups is not obvious, and 
may be due mainly to historical reasons. In the present study we did not use serogroup data in 
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the differentiation between typical and atypical EPEC, and classified all eae positive E. coli 
strains which were stx and bfpA negative as atypical EPEC. 
One bacterial strain was reclassified from atypical to typical EPEC during the study. 
This was done after it was shown to hybridize with the bfpA probe in the microarray 
experiment (Paper III). Primarily it had been recorded as bfpA negative, since only a weak 
amplicon of a different size than expected had been observed in the bfpA PCR analysis (Paper 
II). The EAF plasmid encoding Bfp, essential for the localized adherence characteristic of 
typical EPEC, has been shown to contain sequence variations and deletions in some EPEC 
strains (24,131). Thus, such strains may be classified either as typical or atypical in different 
studies depending on the specific methods used. As in this study, however, they usually 
constitute a minor proportion of the isolates. Therefore variable classification of the strains is 
unlikely to have any substantial influence on the results in most studies (79,218).  
One strain isolated in the case-control study hybridized with probes for the genes 
stxA2f and stxB2f in the microarray experiment. This strain, which had produced a negative 
result for the stx gene in the primary PCR analysis, was reclassified from atypical EPEC 
(Paper II and III) to STEC and was therefore not in included in Paper IV. The stx2f variant of 
the stx gene was originally isolated from feral pigeons (206), and has not been related to 
human disease (69). The false negative PCR result with the stx2f variant may be explained by 
a significant sequence difference between this gene compared to the other stx gene variants. 
For fifteen strains, which hybridized with the stxB1 probe in the microarray analysis 
(Paper III), the classification as atypical EPEC was maintained (Paper IV) on the following 
basis: they did not hybridize with the corresponding stxA1 probe, were negative in PCR 
analysis with stxB1 sequence specific primers, and did not produce shiga toxins (Premier 
EHEC, Meridian Bioscience, US) (unpublished results). We therefore concluded that the gene 
sequences detected by the stxB1 hybridization probe did not represent a complete stxB gene. 
 
5.2  EPEC prevalence 
EPEC was found to be highly prevalent in Norwegian children with diarrhoea, with a 
prevalence of 10.0% and 15.1% in the age groups < 2 years old (Paper I) and < 5 years old 
(Paper II), respectively.  However, EPEC was also detected in 10% of healthy children (Paper 
II).  
Atypical EPEC was the predominant type of EPEC detected, accounting for 42/43 
strains in the retrospective study (Paper I) and for 57/59 strains in the case-control study  
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Table 3. Prevalence of atypical EPEC in case control-studies among children reported in 
recent years. Data compiled from published reports by the author. 
 
Author Year Country Patients 
No. /total (%) a 
Controls 
No. /total (%) a 
P 
Escheverria et al. (55) 1991 Thailand 5/509 (1.0) 6/509 (1.2) Ns 
Gomez et al. (81) 1991 Brazil 32/500 (6.4) 20/500 (4.0) Ns 
Morelli et al. (150) 1994 Italy 2/112 (1.8) 0/56 (0) Ns 
Albert et al. (7) 1995 Bangladesh 0/451 7/602 (1.2) Ns 
Forestier et al. (64) 1996 France 13/220 (5.9) 12/211 (5.7) Ns 
Scaletsky et al. (201) 1999 Brazil 7/40 (17.5) 1/40 (2.5) 0.028 
Knutton et al. (124) 2001 UK 112/1496 (7.5) 32/546 (5.9) Ns 
Vieira et al. (236) 2001 Brazil 32/505 (6.3) 27/505 (5.3) Ns 
Scaletsky et al. (198) 2002 Brazil 13/237 (5.5) 13/231 (5.6) Ns 
Scaletsky et al. (200) 2002 Brazil 6/100 (6.0) 2/100 (2.0) Ns 
Dulguer et al. (52) 2003 Brazil 38/438 (8.7) 27/422 (6.4) Ns 
Nunes et al. (167) 2003 Brazil 11/125 (8.8) 5/98 (5.1) Ns 
Regua-Mangia et al. (186) 2004 Brazil 11/199 (5.5) 6/54 (11.1) Ns 
Robbins-Browne et 
al.(190)b 
2004 Australia 89/696 (12.8) 11/489 (2.3) <0.0001 
Cohen et al. (40) 2005 USA - c /684 (6.5) - c /486 (3.9) <0.05 
Nguyen et al. (164) 2005 Vietnam 39/587 (6.6) 11/249 (4.4) Ns 
Orlandi et al. (172) 2006 Brazil 19/470 (4.0) 2/407 (0.5) 0.006 
Olesen et al.  (171) 2005 Denmark  44/396 (11) 91/714 (13) Ns 
Nataro et al. (159) 2006 USA 20/317 (6.3) 6/56 (10.7) Ns 
Vernacchio et al. (234) 2006 USA 59/482 (12.2) 57/442 (12.9) Ns 
Alikhani et al. (8) 2006 Iran 23/247 (9.3) 13/1108 (1.2) <0.0001 
Hien et al. (92) 2007 Vietnam 5/111 (4.5) 4/111 (3.6) Ns 
a Numbers presented are calculated from available information if not explicitly given in the referred study, and in 
most studies include all eae positive E. coli strains which are EAF and/ or bfpA and stx negative. In some of the 
studies classification was partly based on phenotypic methods. 
b This study included families with at least two children 1-15 years of age. The mean age of subjects with 
diarrhoea was 3.4 years.  
c Only percentages, but not actual figures, of subjects with atypical EPEC available from published study 
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(Paper II, paper III and reclassifications as detailed above). This finding is in line with similar 
reports from other high-income countries (Table 2), although the prevalence of atypical EPEC 
varies considerably (< 5 up to 22 %) between different studies (23,163,206). This variation 
could be due to the epidemiological situation in different geographic regions, but could also 
reflect the population of children studied, study design and diagnostic methods which may 
vary between different studies. One possible explanation for the high prevalence rates 
recorded in this study could be the inclusion criteria used. Research studies based on hospital  
admissions most likely would find different prevalence rates compared to studies of 
community acquired diarrhoea where the majority usually has less severe disease. 
 
5.3  Atypical EPEC - role of in diarrhoea 
Although atypical EPEC was more common in patients (14.7%) than in controls (10.0%), the 
association with diarrhoea was not statistically significant when all subjects with and without 
diarrhoea were compared (OR 1.4, P=0.3) (Paper II). This lack of a statistically significant 
association is consistent with results from numerous other studies (Table 3). However, there 
are also data indicating that atypical EPEC may have a role as a diarrheagenic agent: a) in  
most case control studies (Table 3) a higher prevalence of atypical EPEC has been observed 
in children with diarrhoea than in healthy children; b) in some studies the association between 
atypical EPEC and diarrhoea was significant, either for the group as a whole 
(8,40,172,190,201) or a subgroup (52,236); c) in addition, volunteer studies have shown that 
adult subjects who were given EAF-plasmid cured or bfpA-mutated EPEC strains developed 
diarrhoea, although to a lesser extent than subjects infected with the wild type typical EPEC 
strain (17,135); and d) finally, strains classified as atypical EPEC have been reported to cause 
diarrhoea outbreaks (90,99,237,242,246).  
 The microarray revealed that there are considerable differences in the content of 
virulence genes between the atypical EPEC strains in the study (Paper III). Interestingly, a 
number of putative virulence genes were significantly associated with diarrhoea (Table 4). 
These were the OI-122 pathogenicity island genes efa1/lifA, nleB, nleE and set/ent, lpfAO113, 
the EHEC associated genes ehxA and ureD, and the porcine attaching and effacing gene paa. 
In addition, the association was highly significant (P=0.0008) for the three variants of the lpfA 
genes when they were analysed together.  
In contrast to the above findings, a study from Brazil reported no difference in the 
prevalence of the genes efa1/lifA, lpfAR141 and nleA/espI in atypical EPEC strains between 
children with and without diarrhoea (51). Likewise, in 22 randomly selected atypical EPEC  
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Table 4. Genes significantly associated with diarrhoea in atypical EPEC strains from 
Norwegian children less than five years old with and without diarrhoea. 
 
Gene Gene description Total no. (%) 
Patients 
(n=37) 
Controls
(n=20) b P
c Type of 
associationf 
 
efa1/lifAa 
 
EHEC factor for adherence (efa1)/ 
lymphocyte inhibitory factor A  (lifA) 
 
 
17 (28.8)
 
17 
 
0 
 
0.0002 
 
+ 
nleBa Non-LEE effector protein B encoding 
gene, located on the OI-122  
 
23 (40.4) 21 2 0.0006 + 
nleEa Non-LEE effector protein E encoding 
gene, located on the OI-122 
 
23 (40.4) 21 2 0.0006 + 
set/enta Gene encoding putative enterotoxin, 
similar to ShET2 enterotoxin of S. 
flexneri, located on the OI-122 
 
23 (40.4) 21 2 0.0006 + 
lfpAO113 Gene endcoding major fimbrial 
subunit of long polar fimbriae, first 
described in STEC O113 
 
13 (22.8) 12 1 0.02d + 
ehxA EHEC hemolysin gene, located on 
the EHEC plasmid 
 
8 (14.0) 8 0 0.04e + 
ureD Urease-associated protein, located on 
the EHEC plasmid 
 
7 (12.3) 7 0 0.05e + 
paa Porcine attaching and effacing 
associated protein 
 
34 (59.6) 27 7 0.01 + 
yjaA Hypothetical protein gene, used as 
phylogenetic marker 
 
30 (52.6) 13 17 0.0004 - 
astA Enteroaggregative E. coli heat-stable 
enterotoxin 1 gene 
 
8 (14.0) 2 6 0.02 - 
ibeA Gene encoding an  E. coli invasion 
protein (invasion of the blood-brain 
barrier) 
 
23 (40.4) 11 12 0.05 - 
b1121 Hypothetical protein gene, 
homologous to virulence factor 
 
48 (84.2) 28 20 0.02e - 
a Genes belonging to a pathogenicity island, named OI-122 in the EDL933 genome. 
b  One strain initially identified as atypical EPEC by PCR was reclassified as EHEC when it was 
shown to contain the stx2f  gene by microarray analysis. 
c Fisher’s exact test. 
d When the analysis was done for all lpfA variants together (lpfAO113, lpfA1, and lpfA R141), the 
association was significant with a P-value of 0.0008. 
e Genes no longer significantly associated with diarrhea at the P<0.05 level when strains from 
patients with other pathogenic agents (n=8) were excluded from the analysis. 
f Positive (+) or negative (-) statistical association with diarrhea. 
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strains from Australian children with and without diarrhoea only 3 (13.6%) strains contained 
the efa1 gene, and 2 (9.0%) strains contained the lpfDR141 gene variant (190). The 
inconsistency between the results of these two studies and our own, where 17 of 57 (28.9%) 
strains were efa1/lifA positive and 8 of 57 (14.0%) strains contained the lpfAR141, gene is not 
known, but may be due differences in virulence profile of the atypical EPEC strains. 
However, this will need to be confirmed by comparison of strains from the different 
geographic regions. It is also possible that a subpopulation of efa1/lifA or lpf positive atypical  
EPEC strains could have been missed in the Australian study since only 22 of the 100 atypical 
EPEC strains in that study were tested.  
In the present study virulence genes significantly associated with diarrhoea were 
concomitantly present in many bacterial strains (Paper III). This fact needs to be considered 
when assessing the results. It is possible that the significant result obtained for some of the 
genes may have been due to the concomitant presence of other virulence genes. Analysis of 
the relative contribution of each of the virulence genes was not possible in the present study  
due both to the limited number of strains available and to the concomitant presence of such 
genes in the many strains. 
The importance of some of the virulence genes linked with diarrhoea in this study is 
supported by experimental studies. The OI-122 gene efa1/lifA encodes a protein, 
lymphostatin, which inhibits lymphocyte proliferation and the synthesis of proinflammatory 
cytokines (1,119), but which has also been shown to have adhesive properties (165). Another 
OI-122 gene, the nleB, was also recently reported to be involved in virulence, while no such 
effect was seen for the nleE gene (115). The function of the set/ent gene is not known, but due 
to sequence homology with the ShET2 enterotoxin of Shigella flexneri, a similar function has 
been suggested (112,160). From a study of EHEC it was shown that strains with a complete 
OI-122 were associated with increased epidemic potential and severity of disease (112). In 
another study an additive effect was observed between different OI-122 genes with respect to 
severity and outbreak potential of non-O157 EHEC strains (239). In the same study an nleB 
mutant C. rodentium strain had a decreased virulence potential compared with the wild type 
strain when tested in mice. Conflicting results have been reported regarding the function of 
the long polar fimbriae encoded by the lpf family of genes. Lpf have been reported to be 
involved in adherence in several studies (50,162,227,228).  However, recently Tatsuno et al. 
could not find that it played any role in the pathogenesis for either of EPEC or C. rodentium 
(221). It is possible that the significant results observed for the lpfA genes in our study may  
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Table 5. Distribution of atypical EPEC strains of virulence group I 
and II between subjects with acute and protracted diarrhoea, and 
healthy controls. 
Virulence group 
Diarrhoea? 
I  II  Non-classifiable 
Total 
Acute 8 1 - 9 Yes 
Protracted 10 10 - 20 
 Unknown 6 2 - 8 
No  3a 16 1 20 
Sum  27 29 1 57 
a One strain initially identified as atypical EPEC by PCR was reclassified as 
EHEC when it was shown to contain the stx2f  gene by microarray analysis. 
 
  
have been due to other coexisting factors like the OI-122 genes which were present in most of 
the strains containing lpfA genes.  
There were also genes which were negatively associated with diarrhoea (Table 4). 
Especially for the yjaA gene the association was strong. This gene, which has no known 
function, is closely linked to phylogenetic ancestry, and has therefore been used as a 
phylogenetic marker gene (39). The negative link with diarrhoea for the yjaA gene observed 
in this study may indicate the presence of a phylogenetic lineage of atypical EPEC strains 
lacking diarrheagenic potential. Another possibility could be that the protein encoded by the 
yjaA gene may inhibit other virulence factors present in the strain. Such a negative association 
between a gene and disease has been reported for other pathotypes of E. coli and other 
bacterial species (139,215). The astA gene, which previously was linked with diarrhoea in 
atypical EPEC strains from Brazil (52), was surprisingly found to be negatively associated 
with diarrhoeal disease in the present study (Paper III). 
Based on their content of genes significantly linked with diarrhoea, all but one of the 
atypical EPEC strains could be classified in two virulence groups (Table 5) (Paper III). 
Virulence group I strains containing OI-122 and lpfA genes were mainly present in children 
with diarrhoea, whereas group II strains containing the yjaA gene were more common in 
healthy children than in those with diarrhoea (P<0.001).  
 
5.4  Duration of diarrhoea 
Virulence group I atypical EPEC strains, which were significantly associated with diarrhoea 
in this study, were about equally distributed between children with acute and protracted 
diarrhoea (Table 5). The association of atypical EPEC with protracted diarrhoea observed in 
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Paper II was based on analyses before the information of virulence groups became available 
(Paper III). Table 5 shows that atypical EPEC strains of both virulence group I and II were 
prevalent among children with protracted diarrhoea. However, since strains belonging to 
virulence group II were not statistically associated with diarrhoea, they should most likely be 
considered as colonisers which do not cause disease. The statistical association between 
atypical EPEC and protracted diarrhoea reported in Paper II may therefore have been an 
overestimation. Based on the analysis in virulence groups, virulence group I strains are 
associated with both acute and protracted diarrhoea, while virulence group II strains do not 
appear to have a diarrheagenic potential. On the other hand, we cannot exclude the possibility 
that strains belonging to the latter virulence group, which appear to have a propensity for 
protracted intestinal colonization, do have the potential to cause disease in susceptible 
subjects (154). Virulence group II strains were rarely isolated from patients with acute 
diarrhoea. The reason behind this finding is not clear, but a possible explanation might be that 
intestinal environmental changes during acute diarrhoea disfavour colonization with this type 
of atypical EPEC strains. 
In a study comparing clinical characteristics with infectious aetiology in children 
attending hospital, Nguyen et al. found that the duration of diarrhoea was significantly longer 
in patients infected with atypical EPEC than in children with other enteropathogens or where 
no agents were identified (164). This finding seems to be in agreement with our primary 
observation in Paper II, but not with the analysis based on virulence groups (Paper III). 
Further virulence typing might show whether the atypical EPEC strains in that study also 
belonged to different virulence groups. 
 
5.5  Severity of disease 
In both the retrospective (Paper I) and the case-control study (Paper II) few patients infected 
with atypical EPEC were admitted to hospital due to severe gastroenteritis. This observation 
indicates that atypical EPEC usually does not lead to severe disease, at least not the type of 
atypical EPEC detected in our geographical area. This finding is in agreement with the 
previous observation that EAF-plasmid cured or bfpA-mutated EPEC strains induced milder 
symptoms than typical EPEC (17,135), and also with the observation that Australian patients 
infected with atypical EPEC had less severe symptoms than those infected with rotavirus- and 
Salmonella (163).  
 
5.6  Age distribution 
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Atypical EPEC was more commonly detected in children older than one year than in infants 
(Paper II). This age distribution was surprising since EPEC diarrhoea usually has been 
considered to be as disease in children less than 6-12 months old (134,157). Since many of the 
infants in this study had older siblings with a high probability of atypical EPEC infection, 
they would actually be expected to have a high risk of atypical EPEC infection (Paper II). 
However, our observations of a higher age among children infected with atypical EPEC than 
reported for typical EPEC are in agreement with Australian studies were children with 
atypical EPEC gastroenteritis had a mean age of 3.4 years and 16.9 months in two different 
studies (163,190). In contrast, the rate of infection with eae positive E. coli in infants in 
Guinea Bisseau was very high (232). In a study where infants where followed with frequent 
stool samples from birth for two years, fifty per cent of the cohort were infected with eae 
positive E. coli within 4 months, and almost all had been infected by ten months of age. One 
possible explanation for the discrepancy between these studies may be that the age 
distribution of atypical EPEC infections is different in high and low income countries.  
 
5.7  Quantity of atypical EPEC in stool specimens 
Usually it has been assumed that EPEC bacteria causing diarrhoea will be the predominant E. 
coli strain in the patient’s stools (135,157). In our case-control study there was no difference 
between patients and controls in the relative quantity of atypical EPEC in their stool 
specimens (Paper II), nor when analysed with respect to virulence group (Paper III). These 
results need to be interpreted cautiously, as it is generally difficult to pick colonies from a 
culture plate with mixed growth in a random fashion. Therefore, a subjective element might 
have influenced the results. Nevertheless, the results do indicate that virulence group I 
atypical EPEC may be the cause of diarrhoea even though they are present in low numbers at 
the time of diagnosis. If this finding is confirmed, the prevailing assumption (135,157) that 
atypical EPEC should be regarded as a causative agent only when detected as the predominant 
agent in the patient’s stool, may need to be reconsidered.  
 
5.8  Duration of carriage of atypical EPEC 
In the case-control study persistent colonization (≥1 month) was observed in 14 (28%) of the 
50 children who submitted follow-up specimens (Paper II). Three subjects were still 
colonized after three months and one child even after six months when follow-up was 
terminated. When compared with respect to the virulence group of the infecting atypical 
EPEC strains, subjects infected with virulence group II strains were significantly more often 
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colonized at the time of follow up than those with group I strains (P=0.005) (Paper III). This 
could not be explained by different intervals to the follow up test between the two groups, as 
this interval was actually longer for virulence group II (mean 38.0 days) than for virulence 
group I strains (mean 28.6 days, P= 0.07). This fact supports the finding in this study that 
virulence group II strains are persistent colonizers.  
 
5.9  Genetic and phenotypic characterization of atypical EPEC strains 
Extensive characterization with several methods showed considerable heterogeneity among 
the atypical EPEC strains in this study. Using PFGE analysis we confirmed that the high 
prevalence of atypical EPEC was not due to a clonal outbreak but to endemic infections with 
a high number of distinct atypical EPEC strains (Paper I and IV). Phylogenetic analysis of the 
atypical EPEC strains from the case-control study showed that all four phylogenetic groups 
(A, B1, B2 and D) were represented among the strains (Paper IV). The MLST analysis further 
showed that the atypical EPEC strains within each of the phylogenetic groups belonged to a 
high number of different STs as well as clonal lineages. More than half of the STs were 
detected in only one strain each (Paper IV). There was also evidence of phylogenetic 
incompatibility in the divergence of the atypical EPEC clones, explained at least in part by 
recombinational events. 
 The poor separation between strains belonging to different groups in the phylogenetic 
analysis might be explained by the presence of hybrid strains carrying ancestry from more 
than one source as reported from the E. coli MLST database (242) (Paper IV). Such hybrid 
strains were not identifiable by the PCR method used for the phylogenetic group analysis in 
this study. However, at least four of the STs identified in this study (ST 28, 32, 154, and 206) 
have previously been shown to contain phylogenetic ancestry from more than one source 
(242). 
 Comparison between phylogenetic background and virulence characteristics have 
usually been done only for a limited number of virulence factors (52,80,167,177,187,236) or 
for strains belonging to specific EPEC serotypes (15). The use of data from DNA microarray 
analysis (Paper IV) enabled an extensive characterization of the atypical EPEC strains with 
respect to overall virulence gene content as well as a comparison between virulence profile 
and phylogenetic ancestry. The main division between group B2 strains and the three other 
groups A, B1 and D observed in the phylogenetic analysis was supported by differences in 
virulence profiles. There was also agreement between the two different types of analyses in 
the separation of phylogenetic group B2 strains in two clusters. Strains belonging to the  
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 Table 6. Comparison between virulence classifications based on 
specific genes significantly associated with diarrhoea and overall 
virulence gene content 
Virulence group 
Virulence cluster No. I II Non-classifiable 
Cluster B2-A 9 0 9 - 
Cluster B2-B 15 0 15 - 
Cluster A-B1-D 33 27 5 1 
Sum 57 27 29 1 
 
  
phylogenetic groups A and B1 were not reliably differentiated neither by the phylogenetic 
analysis nor by their overall virulence gene profiles or specific gene content. Group D strains, 
on the other hand, were narrowly scattered at the periphery of this cluster, and was also shown 
to contain significantly more virulence genes that strains belonging to the other virulence 
clusters. The link observed in this study between phylogenetic ancestry and virulence profile, 
overall as well as for many genes separately, may be explained by the requirement of a 
specific genetic background for the acquisition of certain virulence factors (59). 
In the present study two different classifications of virulence profile was used. The first 
(“virulence groups”) was based on virulence genes significantly associated with diarrhoea 
(Paper III), while the second (“virulence clusters”) was based on overall content of all the 
putative virulence genes tested in the microarray analysis (Paper IV). The main difference 
between these two classifications of the atypical EPEC strains was the differentiation of 
phylogenetic group B2 strains (all belonging to virulence group II) in two clusters, and the 
localization of all ten phylogenetic group A strains in one cluster (cluster A-B1-D) (Table 6). 
Among phylogenetic group A strains four belonged to virulence group I and five strains to 
virulence group II. In addition, the one strain which did not fit within any of the two virulence 
groups due to its content of both OI-122 genes and the yjaA gene, belonged to cluster A-B1-
D. 
The efa1/lifA gene most strongly associated with diarrhoea was present in strains 
belonging to the phylogenetic groups A, B1 and D, but not phylogenetic group B2 (Paper IV). 
The other genes statistically associated with diarrhoea were also present in the same three 
phylogenetic groups, except the paa gene which was found in all four groups. The selective 
distribution of these virulence genes, as well as the correlation between phylogenetic ancestry 
and virulence genes described above, seems to be consistent with the notion that a specific 
genetic background may be required for the acquisition of certain virulence factors (59).  
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 Phylogenetic ancestry was less useful as an indicator of diarrheagenic potential than 
specific virulence genes in this collection of atypical EPEC strains. This observation is most 
likely explained by considerable heterogeneity in virulence factors within each of the 
phylogenetic groups. The efa1/lifA gene most strongly associated with diarrhoea in these 
strains (Paper III) was present in only some of the strains within phylogenetic group A and 
B1. On the other hand, the strong negative association with diarrhoea shown for the 
phylogenetic group B2 seems to indicate close association between phylogenetic descent and 
lack of diarrheagenic potential.  
 In this study the LEE region of each strain was classified by its composition of espA, 
espB, tir and eae variants. Typing of LEE genes is of importance in the characterization of 
A/E pathogens since different variants of these genes have been associated with host 
specificity (62,179). The number of variants detected (11 LEE types, Paper IV) was 
comparable with that reported from STEC and EPEC strains in Spain recently (73). However, 
the use of different hybridization probes (20-25-mer probes), as well as different type strains 
for some LEE variants, makes comparison of LEE types between the two studies difficult. In 
contrast to previous reports (35,73) several of the espA, espB, tir and eae variants could be 
observed in combination with more than just one variant of the other LEE genes. This finding 
is consistent, as recently suggested, with horizontal exchange between different strains not 
only of entire LEE sequences, but also of smaller gene elements within the LEE (32). The link 
between certain LEE types and OI-122 genes shown in this study (Paper IV) may be due to 
close proximity of the genomic islands in the chromosome of these atypical EPEC strains, 
similar to what has been shown for O103:H2 EHEC strains (105). 
 The finding of genes in a considerable proportion of the atypical EPEC strains usually 
linked to the EHEC pathotype (Paper III and IV) is consistent with evidence from 
epidemiological and experimental studies showing that atypical EPEC may convert to, or be a 
conversion from, the EHEC pathotype through acquisition or loss of stx genes (18,236,242). 
Such a relationship is also supported by the detection of STs belonging to the phylogenetic 
lineages EHEC1 and EHEC2 among the atypical EPEC strains in the study (Paper IV). It is 
also interesting to observe considerable variability in the content of plasmid genes between 
different strains (Paper IV). This observation is in agreement with reports of extensive 
heterogeneity of large plasmids in STEC (30) and in attaching and effacing (A/E) E. coli of 
animal origin (4). This heterogeneity makes reliable detection of such plasmids with DNA 
based methods difficult without testing for several or all the genes encoded on the plasmid. 
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Finally, serotyping showed that few strains belonged to classical EPEC serogroups 
(O55 and O125ac). The majority of strains belonged to non-EPEC serogroups, or were non-
typable or rough (Paper IV). Similarly, many different H types were present among the 42 
strains were an H type was identified. All the above results confirm the previously reported 
heterogeneity among atypical EPEC strains (52,80,190,236). 
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6  Main conclusions 
• EPEC was frequently isolated from Norwegian children both with and without diarrhoea, 
but was rarely observed in association with severe diarrhoea. 
 
• The majority of EPEC strains were characterized as atypical EPEC. 
 
• Serotyping does no longer appear to be a useful method for the diagnosis of atypical 
EPEC  
 
• Phylogenetic and genetic characterization showed extensive diversity between the atypical 
EPEC strains in the study. 
 
• Several virulence genes in atypical EPEC were statistically associated with diarrhoea. 
 
• The atypical EPEC strains could be classified in two virulence groups based on their 
content of the virulence genes statistically linked with diarrhoea.  
 
• Virulence group II strains, which all belonged to phylogenetic group B2, were not 
associated with diarrhoea, but appeared to be associated with protracted intestinal 
colonization. 
 
• Virulence group I strains, which belonged to the phylogenetic groups A, B1 and D, were 
significantly associated with diarrhoea, and were isolated both from children with acute 
and protracted diarrhoea.  
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7  Future perspectives 
• Further verification of the pathogenicity of the virulence genes identified in this study in 
experimental volunteer studies. 
 
• Clarification of the role of atypical EPEC belonging to virulence group I as diarrheagenic 
agent among children in developing countries. 
 
• Further study of the role of atypical EPEC belonging to virulence group II; diarrheagenic 
potential depending on host factors, and study of specific factors enabling protracted 
intestinal colonization. 
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8  Errata 
In Table 1 of both Papers I and II the nucleotide sequences for the PCR primers for the two 
variants of the stx gene are not correct. The correct primer sequences (5’-3’) are as follows: 
SLT-I F: AAATCGCCATTCGTTGACTACTTCT, SLT-I R: TGCCATTCTGGCAACTCGCGATGCA, SLT-II 
F: CAGTCGTCACTCACTGGTTTCATCA, and SLT-II R: GGATATTCTCCCCACTCTGACACC. 
In Paper III the P-value =0.0008 for the association between the efa1/lifA gene and diarrhoea 
given in the abstract in incorrect. The value P=0.0002 listed in Table 2 is correct. 
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